Conception is a high-growth biotechnology startup at the forefront of reproductive science. By focusing on the generation of functional human eggs from induced pluripotent stem cells (iPSCs), the company is tackling some of the most significant hurdles in fertility treatment today.
Operating in a fast-paced and well-funded environment, the team consists of experts in stem cell, developmental, and synthetic biology. Conception offers a unique opportunity for scientists and researchers to work on groundbreaking technology that has the potential to fundamentally transform human reproductive health.